Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview

6Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Systemic lupus erythematosus (SLE) is a clinicopathologically heterogeneous chronic autoimmune disorder affecting different organs and tissues. It has been reported that there is an increasing rate of SLE incidence among Iranian population. Moreover, the Iranian SLE patients have more severe clinical manifestations compared with other countries. Therefore, it is required to introduce novel methods for the early detection of SLE in this population. Various environmental and genetic factors are involved in SLE progression. Main body: In present review we have summarized all of the reported genes which have been associated with clinicopathological features of SLE among Iranian patients. Conclusions: Apart from the reported cytokines and chemokines, it was interestingly observed that the apoptosis related genes and non-coding RNAs were the most reported genetic abnormalities associated with SLE progression among Iranians. This review clarifies the genetics and molecular biology of SLE progression among Iranian cases. Moreover, this review paves the way of introducing an efficient panel of genetic markers for the early detection and better management of SLE in this population.

Cite

CITATION STYLE

APA

Gachpazan, M., Akhlaghipour, I., Rahimi, H. R., Saburi, E., Mojarrad, M., Abbaszadegan, M. R., & Moghbeli, M. (2021, December 1). Genetic and molecular biology of systemic lupus erythematosus among Iranian patients: an overview. Autoimmunity Highlights. BioMed Central Ltd. https://doi.org/10.1186/s13317-020-00144-y

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free